CDR-404 by CDR-Life for Head And Neck Squamous Cell Carcinoma (HNSC): Likelihood of Approval

CDR-404 is under clinical development by CDR-Life and currently in Phase I for Head And Neck Squamous Cell Carcinoma (HNSC).

Paris Hilton backs California bill requiring sunshine on ‘troubled teen industry’

Celebrity hotel heiress Paris Hilton is backing California lawmakers’ push to increase the transparency of residential teen therapeutic centers by requiring these programs to report

April 17, 2024

Aging reorganizes pancreas circadian transcriptome

A new research paper was published in Aging (listed by MEDLINE/PubMed as “Aging (Albany NY)” and “Aging-US” by Web of Science) Volume 15, Issue 16,

September 6, 2023

Forget ringing the button for the nurse. Patients now stay connected by wearing one.

Patients admitted to Houston Methodist Hospital get a monitoring device about the size of a half-dollar affixed to their chest — and an unwitting role

May 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.